Key Points- Shares of Novavax fell after the vaccine maker reported fourth-quarter revenue and earnings that missed Wall Street’s estimates.- The company also said it expects full-year 2024 sales to come in flat or lower compared to last year.- Still, Novavax narrowed its losses in the quarter from the same period a year ago, even […]
